abs188.txt	pancreatic	cancer	is	the	fourth	leading	cause	of	death		soluble	receptorfor	glycation	end	products	(srage)	which	modulated	by	anti-hypertensive	(ht)medications	has	been	inversely	associated	with	however	theassociation	between	commonly	used	anti-ht	medications	and	risk	pancreaticcancer	unknown	a	total	145	551	postmenopausal	women	from	healthinitiative	(whi)	study	were	included	in	analysis	use	angiotensin	convertingenzyme	inhibitors	(acei)	β-blockers	calcium	channel	blockers	(ccbs)	anddiuretics	was	ascertained	at	baseline	(1993⁻1998)	srage	levels	weremeasured	among	subset	2104	participants	using	an	immunoassay	multivariablecox	proportional	hazard	regression	model	performed	to	estimate	ratios(hrs)	its	95%	confidence	intervals	(cis)	for	associationwith	increased	found	amongusers	short-acting	ccb	(hr	=	1	66	ci	20⁻2	28)	long-term	(≥3	years)users	2	07	42⁻3	02)	compared	users	ofother	average	lower	ccbusers	than	other	(1173	versus	1454	pg/ml	p	=0	038)	non-statistically	significant	reduced	foundamong	0	80	60⁻1	07)	levelswere	higher	(1692versus	>	05)	future	studies	are	warranted	confirm	thesefindings	elucidate	potential	mechanisms	medicationsinfluence	development
